AiCuris is opening first study centers in Germany for its international pivotal phase 3 trial with pritelivir for the treatment of herpes simplex virus infections in immunocompromised patients • MC Services corporate website
14 Jun AiCuris is opening first study centers in Germany for its international pivotal phase 3 trial with pritelivir for the treatment of herpes simplex virus infections in immunocompromised patients